The only international solid state event!
Today crystallisation is among ‘the biggest problems of the pharmaceutical industry’ (George Tranter, Chiralabs). Getting drugs to the market in the most cost efficient way possible while still ensuring they contain as few impurities as possible has never been more vital. The 8th Annual Polymorphism and Crystallisation conference will give answers to the questions these challenges raise.
The 2012 summit will provide an 'excellent range of topics' (Philip Lake, GSK) and create an interactive environment for learning, networking and building key business relationships.Live only at Polymorphism and Crystallisation 2012 speakers will present the latest scientific advances made in key solid state areas including:
Understanding the best time and depth for a polymorphic screen during pharmaceutical development
Characterising co-crystals, how to select the tools to do the correct characterisation tests
Polymorphic scale up
The application of PAT and QbD in pharmaceutical processes
And a business perspective: patenting new polymorphs
Join us next year to ensure process development excellence! Network with industry leaders and turn challenges into opportunities!
For additional information and registration:
Call: +44 (0) 2073689300